Big drugmakers, under pressure to streamline operations in the face of rising costs and slowing sales, are looking to the automotive industry for tips on tuning up their profit engines.
Big Pharma gets a driving lesson from carmakers
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.